Adverse reactions from consumption of oral rabies vaccine baits in dogs in Finland by Nokireki, T. et al.
Nokireki et al. Acta Vet Scand  (2016) 58:53 
DOI 10.1186/s13028-016-0234-3
CASE REPORT
Adverse reactions from consumption 
of oral rabies vaccine baits in dogs in Finland
Tiina Nokireki1*, Martti Nevalainen2, Liisa Sihvonen1,3 and Tuija Gadd1
Abstract 
Background: Oral rabies vaccination of wildlife has effectively reduced the incidence of rabies in wildlife and has led 
to the elimination of rabies in large areas of Europe. The safety of oral rabies vaccines has been assessed in both target 
(red fox and raccoon dog) and several non-target species.
Case presentation: Since 2011, the competent authority in Finland has received a few reports of dogs experiencing 
adverse reactions that have been assumed to be caused by the consumption of baits containing oral rabies vaccine. 
The dogs usually exhibited gastrointestinal symptoms (vomiting, inappetence, constipation or diarrhoea) or behavio-
ral symptoms (restlessness, listlessness and unwillingness to continue hunting).
Conclusions: Nevertheless, these adverse reactions are transient and non-life threatening. Even though the adverse 
reactions are unpleasant to individual dogs and their owners, the benefits of oral rabies vaccination clearly outweigh 
the risks.
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Background
Rabies virus (RABV) infection is maintained in several 
species of wildlife, but rabid dogs are the most important 
source of human rabies infections, especially in Asia and 
Africa. Historically, the dog has been the most important 
host for RABV in Europe, but during the first half of the 
20th century dog rabies was eliminated in most parts of 
Europe. RABV emerged in red foxes (Vulpes vulpes) in 
the Kaliningrad area at the beginning of the 1940s and 
spread within a few decades across Central and Western 
Europe [1]. In 1978, the first oral rabies vaccination cam-
paign for wildlife was conducted in Switzerland, followed 
by other European countries. Oral rabies vaccination has 
effectively reduced the incidence of rabies in wildlife dur-
ing the past three decades in 24 countries and has led to 
its elimination over large areas of Europe [2].
Finland had been free of rabies since 1959, but the dis-
ease reappeared in 1988–1989 in an area of 1700 km2 in 
southeast Finland. Altogether, 66 cases were recorded, 
mostly in raccoon dogs (Nyctereutes procyonoides), but 
also in red foxes and domestic animals. A field trial of 
oral vaccination was initiated in 1988 using SAD B19 
bait, and the outbreak was contained after three oral vac-
cination campaigns and compulsory vaccination of dogs 
in the outbreak area [4]. Finland was declared rabies-free 
again in 1991. However, because of concerns of rabies 
re-emergence over the eastern and southeastern bor-
ders, oral rabies vaccination campaigns have been carried 
out in Finland every year since 1991. Rabies is endemic 
in Russia with 3371 cases reported in 2015 in domes-
tic and wild animals. The Baltic countries have only in 
recent years been able to reduce the number of cases 
and eradicate rabies from their territory [3]. In Finland, 
the vaccination area, the vaccine used, and the number 
of vaccination campaigns per year has varied over time. 
Since 2010, the SAG 2 vaccine (Rabigen, Virbac, France) 
has been used. In 2011, after the Russian federation 
authorities informed about rabies cases in Karelia, Fin-
land extended the vaccination zone from about 5000 km2 
to 10,000 km2 by both widening the zone and extending it 
more north. The number of vaccine baits distributed has 
varied from 160,000 to 360,000 vaccine baits per year.
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SAG 2 is a modified-live rabies vaccine. The strain was 
selected from SAD Bern in a two-step process of amino 
acid mutation. The liquid suspension containing the vac-
cine is presented within a PVC/aluminium sachet. The 
sachet is coated with bait matrix made of fat and fish 
ingredients [5] (Fig.  1). The safety of the vaccine has 
been evaluated in both target (red fox and raccoon dog) 
and several non-target species [6–8]. The administra-
tion of the vaccine at 10 times the recommended dosage 
induced no adverse effects in raccoon dogs [6]. Since this 
vaccine presentation contains tetracycline as a biomarker 
and traces of gentamycin, occasional hypersensitivity 
reactions may be observed in domestic animals that have 
ingested the bait containing oral rabies vaccine [9].
In Finland, oral rabies vaccination takes place in Sep-
tember–October. During autumn, the raccoon dog and 
fox populations are at their largest and the weather con-
ditions are suitable for the bait distribution [7, 8]. It coin-
cides with the active hunting season, when hunting dogs 
are also used. While they are roaming freely in the vac-
cination area, they have the opportunity to consume bait. 
Before 2011, no adverse reactions were reported to the 
competent authority. Since 2011, however, the competent 
authority received a few reports of dogs experiencing 
adverse reactions that are suspected to have been caused 
by the ingestion of baits containing oral rabies vaccine.
Case presentation
During 2011–2014, the competent authorities received 
nine reports from dog owners or veterinarians about 
dogs exhibiting symptoms that were associated with the 
consumption of bait containing oral rabies vaccine during 
hunting. Reported cases occurred in the northern part of 
the vaccination area on the southeastern border (Fig. 2). 
Owners had either seen their dog eat a bait or there had 
been vaccine sachets in the dog’s vomit. However, the 
consumption of bait containing the vaccine was not con-
firmed in all cases. Two cases were considered serious. At 
least three of these dogs were taken to a veterinarian, and 
at least one underwent surgery and one endoscopy. The 
dogs usually exhibited gastrointestinal symptoms (vomit-
ing, inappetence, constipation or diarrhoea) or behavioral 
symptoms (restlessness, listlessness and unwillingness to 
continue hunting) (Table 1). In addition to the reported 
adverse reaction in dogs, a report was received of a child 
who had been handling and tasting bait, although the 
child did not experience any adverse effects. Due to these 
adverse event reports, Section  4.6 of the SPC for the vac-
cine has been amended by the manufacturer as follows: 
‘‘Vomiting due to gastric intolerance (potentially due to 
the aluminium/PVC sachet as part of the bait vaccine) 
has been reported in dogs that have accidentally ingested 
the bait.” 
Conclusions
A small number of cases concerning adverse events in 
dogs due to the consumption of bait containing oral rabies 
vaccines have been recorded, even though it is likely that 
not all cases have been reported to the competent author-
ity. Nevertheless, it appears that taking into consideration 
the quantity of baits containing oral rabies vaccine that Fig. 1 The oral rabies vaccine bait and the PVC/aluminium sachet
Fig. 2 Map presenting the geographical distribution of reported 
cases in the vaccination area in Finland
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has been distributed in the wild, the number of reported 
adverse events is low. The gastrointestinal symptoms are 
probably attributable to gastric intolerance following 
the ingestion of foreign material, i.e., aluminium/PVC 
sachets. Likewise, the other signs reported such as apathy, 
lethargy, or on the contrary, restlessness are likely to be 
related to discomfort caused by the ingestion of multiple 
baits. According to Cliquet et al. [10], dogs consumed vac-
cine bait immediately after presentation, while foxes and 
raccoon dogs were less eager to ingest the bait. Thus, it 
appears that dogs are by nature more likely to consume 
several baits than the target species. It is also noteworthy 
that all other oral rabies baits have the same components. 
The possibility that the antibiotics present in the bait 
could cause reactions in some individuals cannot be ruled 
out. The aminoglycoside antibiotic gentamycin is known 
to induce acute kidney injury in dogs [11].
It is very important that people who live or hunt in the 
vaccination area are aware of the bait distribution, since 
its timing coincides with hunting season. In 2011, the vac-
cination campaign in Finland was extended to areas that 
had not been vaccinated before, and all of the adverse 
event reports came from these areas. It is possible that 
people living and hunting there reported the adverse reac-
tions more readily than people living in the area where 
vaccination has been carried out for years. All reports 
involved hunting dogs as may be expected, because hunt-
ing dogs roam freely over large areas of the vaccinated 
zone. They could easily ingest several baits unnoticed by 
their owner. Hunting is strenuous exercise for dogs. Slight 
adverse symptoms may readily affect their overall perfor-
mance, which is obvious to their owners and reported.
If an owner knows or suspects that a dog has ingested 
bait, the owner could try to induce vomiting. The dog’s 
health should be monitored, and in case of apparent 
serious clinical signs, the owner should contact a veteri-
narian. If such signs could be related to the vaccine bait 
consumption, case should be reported to Finnish Medi-
cines Agency Fimea.
We conclude that even though these adverse reactions 
are unpleasant to individual dogs and their owners, the 
benefits of oral rabies vaccination clearly outweigh the 
risks.
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Table 1 Adverse events in dogs in 2011-2015 reported to the Finnish competent authority due to suspected consump-
tion of bait containing oral rabies vaccine
a  The causality assessment was carried out using the ABON system described in Volume 9B, Guidelines on Pharmacovigilance for Medicinal Products for Veterinary 
Use where categories are as follows: A probable; B possible; O unclassifiable/unassessable; N unlikely to be product related
Case id Year ABONa Dog Municipality Clinical description by the 
owner
Examination and treatment 
by veterinarian
Case 1 2011 A German shorthaired pointer Ilomantsi Vomiting (5 folio capsules) No treatment
Case 2 2011 B Beagle, 1 year Rääkkylä Restlessness, vomiting, listless 
(vomited a folio capsule)
Symptomatic treatment
Case 3 2012 B Norwegian elkhound, male Kitee Vomiting, inappetence, listless No treatment
Case 4 2012 B Finnish spitz, female Ilomantsi Listless, emesis No treatment
Case 5 2012 A Finnish spitz Ilomantsi Listless, emesis, weight loss, 
anorexia, constipation, haemor-
rhagic diarrhoea
X-ray, surgery for removal of foreign 
body
Case 6 2012 A Jämthund (Swedish Jämthund) Ilomantsi Listless, emesis, weight loss, 
anorexia, constipation, haemor-
rhagic diarrhoea
No treatment
Case 7 2012 B Finnish spitz, male Ilomantsi Emesis, listless No treatment
Case 8 2012 O Finnish spitz, male Tuupovaara Hyperactive, confusion, did not 
hunt for 2 days
No treatment
Case 9 2014 A German shorthaired pointer, 
female
Ilomantsi Vomiting X-ray, endoscopy
Page 4 of 4Nokireki et al. Acta Vet Scand  (2016) 58:53 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Received: 14 June 2016   Accepted: 6 September 2016
References
 1. Hanlon C, Childs J. Epidemiology. In: Jackson A, editor. Rabies scientific 
basis of the disease and its management. Oxford: Elsevier; 2013.  
p. 61–122.
 2. Freuling CM, Hampson K, Selhorst T, Schröder R, Meslin FX, Mettenleiter 
TC, et al. The elimination of fox rabies from Europe: determinants of 
success and lessons for the future. Philos Trans R Soc Lond B Biol Sci. 
2013;368:1623.
 3. Rabies Bulletin Europe 2015. http://www.who-rabies-bulletin.org/. 
Accessed 10 Mar 2016.
 4. Nyberg M, Kulonen K, Neuvonen E, Ek-Kommonen C, Nuorgam M, 
Westerling B. An epidemic of sylvatic rabies in Finland—descriptive epi-
demiology and results of oral vaccination. Acta Vet Scand. 1992;33:43–57.
 5. Lafay F, Bénéjean J, Tuffereau C, Flamand A, Coulon P. Vaccination against 
rabies: construction and characterization of SAG2, a double avirulent 
derivative of SADBern. Vaccine. 1994;12:317–20.
 6. Cliquet F, Guiot AL, Munier M, Bailly J, Rupprecht CE, Barrat J. Safety 
and efficacy of the oral rabies vaccine SAG2 in raccoon dogs. Vaccine. 
2006;24:4386–92.
 7. Scientific Panel on Animal Health and Welfare. Update on oral vaccination 
of foxes and raccoon dogs against rabies. European Food Safety Author-
ity. http://www.efsa.europa.eu/sites/default/files/scientific_output/files/
main_documents/4164.pdf Accessed 28 July 2016.
 8. Report of the Scientific Committee on Animal Health and Animal Welfare. 
The oral vaccination of foxes against rabies. European Commission. 
http://foxrabiesblueprint.org/IMG/pdf/pdf_116_eu_scientific_report_
orv_en.pdf Accessed 28 July 2016.
 9. European Medicines Agency. Rabigen SAG2 summary of product char-
acteristics. http://www.ema.europa.eu/docs/en_GB/document_library/
EPAR_-_Product_Information/veterinary/000043/WC500068129.pdf 
Accessed 27 July 2016.
 10. Cliquet F, Barrat J, Guiot AL, Caël N, Boutrand S, Maki J, et al. Efficacy and 
bait acceptance of vaccinia vectored rabies glycoprotein vaccine in 
captive foxes (Vulpes vulpes), raccoon dogs (Nyctereutes procyonoides) and 
dogs (Canis familiaris). Vaccine. 2008;26:4627–38.
 11. McDuffie JM, Gao J, Ma J, La D, Bittner A, Sonee M, et al. Novel genomic 
biomarkers for acute gentamicin nephrotoxicity in dog. Open J Mol 
Integr Physiol. 2013;3:125–33.
